SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-24-094677
Filing Date
2024-04-12
Accepted
2024-04-12 16:15:00
Documents
9

Document Format Files

Seq Description Document Type Size
1 POS AM d821472dposam.htm POS AM 605852
2 EX-5.1 d821472dex51.htm EX-5.1 45970
3 EX-5.2 d821472dex52.htm EX-5.2 28643
4 EX-23.3 d821472dex233.htm EX-23.3 2286
5 EX-FILING FEES d821472dexfilingfees.htm EX-FILING FEES 31298
6 GRAPHIC g821472g0406082107863.jpg GRAPHIC 5930
7 GRAPHIC g821472g0406082108050.jpg GRAPHIC 4284
8 GRAPHIC g821472g04g04.jpg GRAPHIC 39527
9 GRAPHIC g821472g53e48.jpg GRAPHIC 3115
  Complete submission text file 0001193125-24-094677.txt   784692
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-275932 | Film No.: 24841628
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)